In vitro and animal experiments further showed that the BM microenvironment of MDS can induce the overexpression of immune checkpoint molecules such as PD-1/PD-L1 by activating MDSCs and specific cytokines (53, 56). This evidence concerns the gene PDCD1 and myelodysplastic syndrome.